Protibea Therapeutics
Georgetown, US · Founded 2021 · Delaware corporation
Founders & leadership
JM
Jim MoriartyExecutive
WC
William ChamberlininChief Science Officer
Board
YG
Yu GeBoard director
HO
Harry OkenBoard director
Reported raises · per SEC filings
Form D private placements$970K disclosed across 2 rounds · 2021–2025
▶$200KraisedAug 2025 · 2 investors · Other Health CareRule 506(b)
▶$200KraisedAug 2025 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jim MoriartyExecutive Officer, Director
- Yu GeDirector
- William ChamberlinExecutive Officer, Director
- Harry OkenDirector
- Offering amount
- $11.7M
- Amount sold
- $200K
- Minimum investment
- $100K
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$770KraisedMay 2021 · 8 investors · OtherRule 506(b)
▶$770KraisedMay 2021 · 8 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Yu GeExecutive Officer, Director
- William Mann ChamberlinExecutive Officer, Director
- Offering amount
- $1.2M
- Amount sold
- $770K
- Minimum investment
- $75K
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Protibea Therapeutics raised?
- Protibea Therapeutics has disclosed $970K raised across 2 rounds.
- Where is Protibea Therapeutics headquartered?
- Protibea Therapeutics is headquartered in Georgetown, US.